<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2810433&amp;fmt=gif">

Thought. Leadership.

Innovations, investments, strategies and opportunities introduced at the speed of business.

SAN FRANCISCO—Thoma Bravo LLC, a leading private equity investment firm, today announced that it has completed its sale of Mediware Information Systems, a leader in software for healthcare services providers, to TPG Capital.

“When we took Mediware private in 2012, we backed a tremendous franchise and management team with a unique vision to expand beyond its clinical marketplaces into post-acute categories. Four years later the company has more than doubled its revenues and, through a series of strategic investments, built out one of the largest alternative care franchises in the world,” said Seth Boro, a managing partner at Thoma Bravo. “We feel confident that Mediware will continue to thrive under its new partnership with TPG.”

Mediware is a leading supplier of software as a service (“SaaS”) and other software platforms for healthcare and human services providers and payors across acute, non-acute and community-based sites of care. Primary product categories include non-acute care, human and social services, blood management as well as medication management. Mediware prides itself on delivering high-quality solutions to meet the demands of complex workflows in demanding regulatory environments.

“Thoma Bravo’s support has been central to our success over the past four years. Their operational and strategic expertise has bolstered our growth. Working together, we’ve been able to significantly enhance Mediware’s place as a global leader in software for healthcare and human services providers,” said Thomas Mann, President and CEO of Mediware. “We’re looking forward to maintaining this positive growth trajectory as new partners with TPG.”

About Thoma Bravo
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. With a series of funds representing more than $17 billion in capital commitments, Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make accretive acquisitions intended to accelerate revenue and earnings, with the goal of increasing the value of the business. Representative past and present portfolio companies include industry leaders such as Blue Coat Systems, Deltek, Digital Insight, Global Healthcare Exchange, Hyland Software, PowerPlan, Riverbed, SolarWinds, SonicWall, Sparta Systems and TravelClick. The firm has offices in San Francisco and Chicago. For more information, visit www.thomabravo.com.

About Mediware
Since 1980, Mediware has provided software solutions to healthcare providers and has since expanded to serve many state and federal agencies. Mediware’s solutions are perfect for high-growth, complex patient care environments that remain underserved by existing vendors. The company employs more than 650 subject matter experts who deeply understand business and care processes in highly specialized acute, non-acute, and community-based care settings and have years of experience integrating systems. Mediware’s portfolio of solutions currently includes human and social services, blood solutions, cellular therapy, homecare, medication management, rehabilitation, and respiratory therapy. For more information about Mediware products and services, visit www.Mediware.com.